Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16923522rdf:typepubmed:Citationlld:pubmed
pubmed-article:16923522lifeskim:mentionsumls-concept:C0019829lld:lifeskim
pubmed-article:16923522lifeskim:mentionsumls-concept:C0035020lld:lifeskim
pubmed-article:16923522lifeskim:mentionsumls-concept:C0032743lld:lifeskim
pubmed-article:16923522lifeskim:mentionsumls-concept:C0085973lld:lifeskim
pubmed-article:16923522lifeskim:mentionsumls-concept:C0007320lld:lifeskim
pubmed-article:16923522pubmed:issue8 Suppllld:pubmed
pubmed-article:16923522pubmed:dateCreated2006-8-22lld:pubmed
pubmed-article:16923522pubmed:abstractTextFDG-PET imaging is more frequently being used to stage malignant Lymphoma and monitor response to therapy. However, FDG-PET is not a tumor specific substance and increased accumulation may be seen in a variety of benign entities, our case exemplifies this problem and underline the importance of a biopsy.lld:pubmed
pubmed-article:16923522pubmed:languageenglld:pubmed
pubmed-article:16923522pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16923522pubmed:citationSubsetIMlld:pubmed
pubmed-article:16923522pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16923522pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16923522pubmed:statusMEDLINElld:pubmed
pubmed-article:16923522pubmed:monthAuglld:pubmed
pubmed-article:16923522pubmed:issn1592-8721lld:pubmed
pubmed-article:16923522pubmed:authorpubmed-author:AltavillaGius...lld:pubmed
pubmed-article:16923522pubmed:authorpubmed-author:NavarraGiusep...lld:pubmed
pubmed-article:16923522pubmed:authorpubmed-author:CavallariVitt...lld:pubmed
pubmed-article:16923522pubmed:authorpubmed-author:PitiniVincenz...lld:pubmed
pubmed-article:16923522pubmed:authorpubmed-author:ArrigoCarmela...lld:pubmed
pubmed-article:16923522pubmed:authorpubmed-author:NaroClaudiaClld:pubmed
pubmed-article:16923522pubmed:issnTypeElectroniclld:pubmed
pubmed-article:16923522pubmed:volume91lld:pubmed
pubmed-article:16923522pubmed:ownerNLMlld:pubmed
pubmed-article:16923522pubmed:authorsCompleteYlld:pubmed
pubmed-article:16923522pubmed:paginationECR38lld:pubmed
pubmed-article:16923522pubmed:meshHeadingpubmed-meshheading:16923522...lld:pubmed
pubmed-article:16923522pubmed:meshHeadingpubmed-meshheading:16923522...lld:pubmed
pubmed-article:16923522pubmed:meshHeadingpubmed-meshheading:16923522...lld:pubmed
pubmed-article:16923522pubmed:meshHeadingpubmed-meshheading:16923522...lld:pubmed
pubmed-article:16923522pubmed:meshHeadingpubmed-meshheading:16923522...lld:pubmed
pubmed-article:16923522pubmed:meshHeadingpubmed-meshheading:16923522...lld:pubmed
pubmed-article:16923522pubmed:meshHeadingpubmed-meshheading:16923522...lld:pubmed
pubmed-article:16923522pubmed:year2006lld:pubmed
pubmed-article:16923522pubmed:articleTitlePitfalls of positron emission tomography for assessing relapse in Hodgkin's disease: a case report.lld:pubmed
pubmed-article:16923522pubmed:affiliationDepartment of 1Oncology, University of Messina, Italy. pitini@ciaoweb.itlld:pubmed
pubmed-article:16923522pubmed:publicationTypeJournal Articlelld:pubmed